Safety Consequences of Off-Label Drugs Used for COVID-19.
作者信息
Dasgupta Nabarun
机构信息
Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
出版信息
Drug Saf. 2021 Apr;44(4):399-402. doi: 10.1007/s40264-021-01056-0. Epub 2021 Mar 5.
Abstract
摘要
相似文献
1
Safety Consequences of Off-Label Drugs Used for COVID-19.用于治疗新冠肺炎的超说明书用药的安全性后果。
Drug Saf. 2021 Apr;44(4):399-402. doi: 10.1007/s40264-021-01056-0. Epub 2021 Mar 5.
2
Assessment of novel technologies in healthcare - off-label use of drugs and the ethics of implementation and distribution of COVID-19 vaccines.医疗保健领域新技术评估——药物的超说明书使用以及新冠疫苗的实施与分配伦理
Einstein (Sao Paulo). 2022 Jan 5;19:eED6840. doi: 10.31744/einstein_journal/2021ED6840.
3
Assessment of Awareness and Experience of Using off-label Drugs by Doctors of Clinical Specialties.临床专科医生对超说明书用药的认知和使用情况的评估。
Kardiologiia. 2021 May 31;61(5):41-50. doi: 10.18087/cardio.2021.5.n1510.
4
Targeting Neuroinvasion by SARS-CoV-2: Emerging Trends in Drug and Antibody Delivery to Combat COVID-19.针对 SARS-CoV-2 的神经入侵：用于抗击 COVID-19 的药物和抗体递送至新兴趋势。
ACS Chem Neurosci. 2021 Jul 21;12(14):2555-2557. doi: 10.1021/acschemneuro.1c00372. Epub 2021 Jul 6.
5
American College of Medical Toxicology (ACMT) Cautions Against Off-Label Prescribing of Ivermectin for the Prevention or Treatment of COVID-19.美国医学毒理学学会（ACMT）对伊维菌素用于预防或治疗COVID-19的非标签处方发出警告。
J Med Toxicol. 2022 Jan;18(1):69-70. doi: 10.1007/s13181-021-00866-z. Epub 2022 Jan 10.
6
Letter to the Editor in response to the article 'Candidate drugs against SARS-CoV-2 and COVID-19'.致编辑的信：回应《抗SARS-CoV-2和COVID-19的候选药物》一文
Pharmacol Res. 2021 Jan;163:105285. doi: 10.1016/j.phrs.2020.105285. Epub 2020 Nov 4.
7
ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic.美国毒理学会立场声明：COVID-19大流行期间的超说明书用药
J Med Toxicol. 2020 Jul;16(3):342-345. doi: 10.1007/s13181-020-00784-6. Epub 2020 Jun 4.
8
COVID: Its compassionate use.新冠病毒：其同情用药。
J Vasc Nurs. 2020 Dec;38(4):163. doi: 10.1016/j.jvn.2020.11.001.
9
Recent Advances on Drugs and Vaccines for COVID-19.新冠病毒药物和疫苗的最新进展
Inquiry. 2021 Jan-Dec;58:469580211055630. doi: 10.1177/00469580211055630.
10
Are glomerular patients treated with immunosupressed drugs more protected against sever SARS-Covid -2?接受免疫抑制药物治疗的肾小球疾病患者对重症SARS-CoV-2的抵抗力是否更强？
Semin Arthritis Rheum. 2020 Dec;50(6):e4. doi: 10.1016/j.semarthrit.2020.09.004. Epub 2020 Sep 22.
引用本文的文献
1
Erythromycin, retapamulin, pyridoxine, folic acid, and ivermectin inhibit cytopathic effect, papain-like protease, and M enzymes of SARS-CoV-2.红霉素、瑞他帕林、吡哆醇、叶酸和伊维菌素抑制 SARS-CoV-2 的细胞病变效应、木瓜蛋白酶样蛋白酶和 M 酶。
Front Cell Infect Microbiol. 2023 Nov 27;13:1273982. doi: 10.3389/fcimb.2023.1273982. eCollection 2023.
2
Use of Off-Label Drugs in COVID-19: Clinicians' Perceptions Based on a Cross-Sectional Observational Study.新冠疫情中未按药品说明书用药情况：基于横断面观察研究的临床医生认知
Cureus. 2023 Jul 13;15(7):e41819. doi: 10.7759/cureus.41819. eCollection 2023 Jul.
本文引用的文献
1
The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article.印度麻醉医师对新冠病毒羟氯喹预防的认知：一项基于调查的原创文章
J Anaesthesiol Clin Pharmacol. 2020 Oct-Dec;36(4):471-476. doi: 10.4103/joacp.JOACP_379_20. Epub 2020 Nov 5.
2
Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor's Perspective.全球 COVID-19 相关药物利用安全性监测的安全性数据库汇总：赞助商的观点。
Drug Saf. 2021 Jan;44(1):95-105. doi: 10.1007/s40264-020-01035-x. Epub 2020 Dec 22.
3
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.用于治疗新冠肺炎的抗病毒药物 repurposed - 世界卫生组织团结试验中期结果
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
4
Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study.精神障碍与羟氯喹治疗 2019 年冠状病毒病（COVID-19）：一项 VigiBase 研究。
Drug Saf. 2020 Dec;43(12):1315-1322. doi: 10.1007/s40264-020-01013-3. Epub 2020 Oct 19.
5
Conspiracy Beliefs, Rejection of Vaccination, and Support for hydroxychloroquine: A Conceptual Replication-Extension in the COVID-19 Pandemic Context.阴谋论信念、拒绝接种疫苗以及对羟氯喹的支持：COVID-19大流行背景下的概念性重复研究与扩展
Front Psychol. 2020 Sep 18;11:565128. doi: 10.3389/fpsyg.2020.565128. eCollection 2020.
6
7
Using a Global Pandemic as a Teachable Moment to Promote Vaccine Literacy and Build Resilience to Misinformation.利用全球大流行作为一个教育契机，以促进疫苗知识普及并增强对错误信息的抵御能力。
Am J Public Health. 2020 Oct;110(S3):S284-S285. doi: 10.2105/AJPH.2020.305906.
8
A Prologue to the Special Issue: Health Misinformation on Social Media.特刊前言：社交媒体上的健康错误信息
Am J Public Health. 2020 Oct;110(S3):S270-S272. doi: 10.2105/AJPH.2020.305943.
9
Limited Role of Bots in Spreading Vaccine-Critical Information Among Active Twitter Users in the United States: 2017-2019.美国活跃推特用户中，机器人在传播疫苗负面信息方面作用有限：2017-2019 年。
Am J Public Health. 2020 Oct;110(S3):S319-S325. doi: 10.2105/AJPH.2020.305902.
10
Off-Label Use of Chloroquine and Hydroxychloroquine for COVID-19 Treatment in Africa Against WHO Recommendation.在非洲，违反世界卫生组织的建议将氯喹和羟氯喹用于治疗新冠肺炎的非标签用药情况。
Res Rep Trop Med. 2020 Sep 17;11:61-72. doi: 10.2147/RRTM.S269936. eCollection 2020.
Zotero 插件